HomeNew
Latest
E-paper
Companies
Economy
Finance
Budget
Industry
Markets
External Affairs Defence Security
World News
Opinion
India News
Technology
Specials
Partner Content
Multimedia
sports
Cricket
Lifestyle
Entertainment
Social Viral
Health
BS Decoded
Books
Education
NewslettersNew
Video Gallery
WebstoriesNew
Politics
Management
Sudoku
Crossword
BS Apps
Explore Business Standard
BFSI Insight Summit
Events
About Us
BS Support
Popular Search
Don’t miss the latest developments in business and finance.
Pricing regulator closely watching prices of diabetes drug going off patent
Regulator looking to cap prices of Sitagliptin, Linagliptin and combinations
Generic gliptin's market grows at the expense of patented medicines
Once the generic version has more trial data, it's most likely to obliterate its patented counterparts in the future
